- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02679326
Plantar Fasciitis and Therapeutic Ultrasound
October 3, 2017 updated by: Assuta Hospital Systems
The Efficacy of Treating Plantar Fasciitis With Therapeutic Ultrasound
The purpose of this study is to determine whether Therapeutic Ultrasound is effective in the treatment of Plantar fasciitis (PF).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Plantar fasciitis (PF) is the main cause of pain in the bottom of the heel.
According to the American Physical Therapy Association guidelines since 2008, many treatments have been described to correct the problem, but there are very few high level randomized trials that proved them.
Although not mentioned even in clinical treatment guidelines in PF, one of the most common conservative treatments for use, in general and Israel in particular, is a therapeutic ultrasound device.
Despite this widespread use, there are very few research evidence which examining the effectiveness of this device for the treatment of PF.
The purpose of this study is to evaluate the effect of therapeutic ultrasound versus sham ultrasound on pain, function and quality of life of patients with PF.
Our hypothesis is that the use of ultrasound parameters that cause an increase in the target tissue heat (from 1.75 to 1 W/cm2, Continues intensity of 1 MHZ) will result in a significant improvement than placebo.
To evaluate this hypothesis, we will do a prospective, controlled, randomized, double-blind interventional clinical study.
The study population will include 60 patients, aged 18 or older, suffering from PF and meet inclusion criteria.
Subjects will be divided randomly into study or control group, Both groups will receive stretching Instructions, when the study group will Receive active ultrasound and the control group will Receive sham ultrasound.
Both groups will receive 8 treatments, twice a week.
Study Type
Interventional
Enrollment (Actual)
51
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Darom
-
Rehovot, Darom, Israel
- Maccabee Health Services Physical therapy Clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Worsening symptoms first steps in the morning or at the beginning of walking after sitting for long periods, and after long walking or standing.
- Pain at the bottom of the heel produced by weight bearing or local press.
- Pain level 3 or higher on NPRS at first steps in the morning.
- Tenderness, swelling, or both in the region of proximal plantar fascia and at medial plantar tuberosity of the calcaneous.
- Gradual development of pain at the bottom of the heel.
Exclusion Criteria:
- Peripheral neuropathy.
- Tarsal tunnel syndrome (TTS) \ Fat Pad Syndrome (FPS).
- Calcaneal cyst, Fracture or bone cancer.
- Osteo Arthritis (OA) of the foot fingers or Rheumatoid arthritis (RA).
- Foot surgery at the last year.
- Steroid injections at the last six months.
- Pregnancy.
- Foot infection or diabetic foot.
- Stress fractures of the heel.
- Unavailability in advance to participate in research.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: study group
will receive stretching guidance and high level active Ultrasound
|
|
Placebo Comparator: control group
will receive stretching guidance and very low level of Ultrasound
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numerical Pain Rating Scale (NPRS) at morning
Time Frame: at morning after 4 weeks of treatment
|
pain level at the heel at the first step in the morning.
|
at morning after 4 weeks of treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NPRS during the day
Time Frame: 1 day
|
pain level during the day.
|
1 day
|
Foot & Ankle computerized adaptive test (CAT)
Time Frame: 2 & 4 weeks of treatment
|
Questionnaire of quality of life
|
2 & 4 weeks of treatment
|
Algometric test
Time Frame: 4 weeks of treatment
|
Average of 3 testing of Pressure on the medial tuberosity
|
4 weeks of treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Ron Ben-izhak, PHD, Maccabi Healthcare Services, Israel
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Actual)
May 28, 2017
Study Completion (Actual)
May 28, 2017
Study Registration Dates
First Submitted
February 7, 2016
First Submitted That Met QC Criteria
February 9, 2016
First Posted (Estimate)
February 10, 2016
Study Record Updates
Last Update Posted (Actual)
October 4, 2017
Last Update Submitted That Met QC Criteria
October 3, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4/2015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Plantar Fasciitis
-
University of VirginiaNot yet recruitingPlantar Fascitis | Plantar Fasciopathy | Plantar Fasciitis, Chronic | Plantar Fasciitis of Both Feet | Plantar Fasciitis of Right Foot | Plantar Fasciitis of Left FootUnited States
-
Cairo UniversityNot yet recruiting
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...RecruitingPlantar FascitisItaly
-
Chinese University of Hong KongRecruiting
-
Istanbul Medeniyet UniversityNot yet recruiting
-
Chinese University of Hong KongRecruitingPlantar FascitisHong Kong
-
Stanford UniversityNot yet recruitingPlantar Fascitis
-
Hospital for Special Surgery, New YorkActive, not recruiting
-
Riphah International UniversityCompletedPlantar FascitisPakistan
-
Universidad Complutense de MadridUnknownPlantar Fasciitis | Ultrasound Therapy | Plantar Fasciitis, ChronicSpain
Clinical Trials on Therapeutic ultrasound
-
Chung Shan Medical UniversityCompleted
-
Sirindhorn National Medical Rehabilitation CentreCompletedMyofascial Pain SyndromesThailand
-
Bursa Yüksek İhtisas Education and Research HospitalCompleted
-
Cairo UniversityRecruiting
-
State University of New York at BuffaloCompletedAdult Females | Bilateral Masseter MyalgiaUnited States
-
Fatih Sultan Mehmet Training and Research HospitalCompleted
-
Vibrato Medical, Inc.Active, not recruitingPeripheral Arterial Disease (PAD)United States
-
Universidad Complutense de MadridUnknownPlantar Fasciitis | Ultrasound Therapy | Plantar Fasciitis, ChronicSpain
-
Vibrato Medical, Inc.RecruitingPeripheral Arterial DiseaseUnited States
-
Superior UniversityRecruiting